Nagpur sees a surge in dengue cases every monsoon, but relief may be on the way, with a domestically developed dengue vaccine now in its third phase of trials, experts said in the city. Along with one Indian firm, two foreign pharmaceutical companies are also developing dengue vaccines. If the trials proceed smoothly, the indigenous vaccine could be available in the market within the next six to eight months, pending regulatory approval.
The information was shared by Dr Paramanand Andankar at a dengue awareness workshop for paediatricians organised by an NGO at a hall on North Ambazari Road. The session was attended by senior paediatrician Dr Uday Bodhankar, medical college vigilance officer Dr Avinash Gawande, and Maharashtra Medical Council administrator Dr Vicky Raghwani, among others. Dr Rajendra Sonawane and Dr Shirish Kanchariya provided technical guidance.
Experts noted there is currently no specific antiviral drug for dengue; treatment is symptom-based, focusing on hydration, nutrition, fever control and monitoring for complications such as a drop in platelet count, bleeding, shock or organ failure. Doctors advised parents to seek prompt medical attention if children develop appetite loss or weakness during fever. The trial vaccine reportedly requires two doses three months apart.
👉 Click here to read the latest Gujarat news on TheLiveAhmedabad.com